echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Plant Extracts News > US FDA requires opioid labeling to emphasize risks

    US FDA requires opioid labeling to emphasize risks

    • Last Update: 2013-09-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The U.S Food and Drug Administration announced on its website on Tuesday that it requires opioid manufacturers to modify the labels of related products, emphasizing the dangers and deadly consequences of opioid abuse In the new resolution, the US FDA proposed that the use of opioid analgesics should be changed from the indication of moderate to severe pain to that of severe pain only The U.S FDA proposed the resolution because of the increasing cases of painkillers abuse and deaths in the past few years In a conference call, the FDA said opioid long-acting mechanisms play a "very important role" in drug abuse and deaths In 2010, a total of 16651 people died as a result of opiate abuse Opioids work by changing the human brain's perception of pain, usually in the form of tablets, liquid or skin patches Opioids include morphine, oxycodone and fentanyl According to the data of China's State Food and drug administration, the domestic companies that produce opioid products include Southwest Pharmaceutical (600666 SZ), Northeast Pharmaceutical (000597 SZ) and Guoyao (600511 SH).
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.